S. Ted Treves, MD, Receives SNMMI 2013 Georg Charles de Hevesy Nuclear Pioneer Award

June 9, 2013

S. Ted Treves, MD, Receives SNMMI 2013 Georg Charles de Hevesy Nuclear Pioneer Award

Harvard professor honored for his work in pediatric nuclear medicine

Vancouver, British Columbia — S. Ted Treves, MD, professor of radiology (nuclear medicine) and director of the Joint Program in Nuclear Medicine (JPNM) at Harvard Medical School, has been named as this year’s recipient of the Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to nuclear medicine. Treveswas presented the award by SNMMI—an international scientific and medical organization—during its 2013 Annual Meeting, June 8-12 in Vancouver, British Columbia.

In addition to his positions at Harvard Medical School, Trevesserves in several capacities at Brigham & Women’s Hospital, the Dana-Farber Cancer Institute and Boston Children’s Hospital. Treves founded the first division of nuclear medicine at Boston Children’s Hospital and served at its chief for more than 40 years. He is a founding member of the JPNM and has served as director of its Residency Training Program in Nuclear Medicine. He has been a member of the U.S. Food and Drug Administration Radiopharmaceutical Advisory Committee and serves as a reviewer for several scientific journals and on many editorial boards. He also served as a member of the American Board of Nuclear Medicine, of which he is a lifetime member. Treves founded the first Boston Children’s Hospital Small Animal Imaging Laboratory (SAIL).

“Dr. Treves has contributed greatly to the field of nuclear medicine and molecular imaging, particularly in his work with pediatric patients,” said Frederic H. Fahey, DSc, 2012-2013 SNMMI president. “He has been an innovator and leader in systems integration in medical imaging, developing new diagnostic techniques and evaluating new radiopharmaceuticals—all with the end goal of optimizing nuclear medicine imaging in children. Most recently, he has been investigating the application of new technologies in order to optimize imaging and reduce the radiation dose to children undergoing nuclear medicine procedures. In addition, his work as an educator and advisor— including the publication of his textbooks on pediatric nuclear medicine—has changed the way that pediatric nuclear medicine and molecular imaging is practiced.”

Treves’ research interests include the development and evaluation of diagnostic radionuclide methods, with emphasis in physiologic evaluation and pediatric applications. As the leader of the Image Gently Nuclear Medicine Group, he has led initiatives toward radiation dose reduction in pediatric nuclear medicine, culminating with the 2010 North American Consensus Guidelines for Pediatric Radiopharmaceutical Administered Doses. Treves has also been instrumental in the development of new radiopharmaceutical agents and has several inventions and patents in his name, including a patient-specific method for the detection of seizures. He has written more than 360 journal articles, books and book chapters on these topics.

Treves earned his medical degree from the University of Buenos Aires in Argentina and completed a residency in nuclear medicine at Royal Victoria Hospital in Montreal, Canada. At Yale-New Haven Hospital in New Haven, Conn., he completed an additional residency in nuclear medicine, as well as two fellowships in radiology and nuclear medicine. He is a diplomate of the American Board of Nuclear Medicine.

Multiple honors have been awarded to Treves for his contributions to nuclear medicine. He is the recipient of the 1987 SNMMI George V. Taplin Award, the 2004 SNMMI New England Chapter Holman-Kaplan Lectureship Award and the first SNMMI Pediatric Imaging Council Conway-Treves Senior Investigator Award (2012), named in his honor. He also was named Mentor of the Year from the American College of Nuclear Medicine in 2007.

“I am deeply honored and overwhelmingly delighted to receive the SNMMI de Hevesy Award,” said Treves. “It is a great honor to be recognized by my colleagues. Nuclear medicine is my love, and I have enjoyed every moment working in such an extraordinarily wonderful field. I hope that I will be able to continue with my work in the years to come.”

Each year, SNMMI presents the Georg Charles de Hevesy Nuclear Medicine Pioneer Award to an individual for outstanding contributions to the field of nuclear medicine. De Hevesy received the 1943 Nobel Prize in chemistry for his work in determining the absorption, distribution, metabolism and elimination of radioactive compounds in the human body. His work led to the foundation of nuclear medicine as a tool for diagnosis and therapy, and he is considered the father of nuclear medicine. SNMMI has given the de Hevesy Award every year since 1960 to honor groundbreaking work in the field of nuclear medicine.

The list of previous recipients of this award includes numerous Nobel laureates—such as Ernest Lawrence, who built the world’s first cyclotron for the production of radionuclides, and Glenn Seaborg, who discovered more than half a dozen new elements.


About the Society of Nuclear Medicine and Molecular Imaging

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today’s medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.

SNMMI’s more than 19,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.